Prevalence of Foot At-Risk and its Associated Characteristics among Outpatients with DiabetesMellitus in a Peruvian Public Hospital

Q3 Medicine
Marlon Yovera-Aldana, S. Perez-Cavero, Isabel Pinedo-Torres, Carlos Zubiate-López
{"title":"Prevalence of Foot At-Risk and its Associated Characteristics among Outpatients with DiabetesMellitus in a Peruvian Public Hospital","authors":"Marlon Yovera-Aldana, S. Perez-Cavero, Isabel Pinedo-Torres, Carlos Zubiate-López","doi":"10.1900/RDS.2022.18.1","DOIUrl":null,"url":null,"abstract":"OBJECTIVE To assess the prevalence of patients at risk of developing diabetic foot complications (i.e. foot at-risk) and its clinical components according to the updated International Working Group on Diabetic Foot (IWGDF) criteria and to describe demographic and diabetes-related characteristics. METHODS We conducted a cross-sectional study at María Auxiliadora Hospital between 2017 and 2018. The criteria for foot at-risk in the IWGDF 2019 risk stratification system are classified into four risk categories, R0-R3, ranging from no peripheral arterial disease (PAD) and no peripheral neuropathy (PN) to the presence of PAD or PN in combination with previous foot ulcer, amputation, or end- stage renal disease (R3). According to this system, we obtained prevalence ratios (PR) of foot at-risk categories dependent on sex, age, diabetes duration, and Total Symptom Score. A sample size of 402 subjects was included in the study. RESULTS Subjects included had a mean age of 61 years, and 66% were female. There were no patients with type 1 diabetes, and 59% percent had adiabetes duration of less than ten years. The prevalence of foot at-risk was 54.3% defined by the IWGDF 2019 criteria, which gave prevalence17% higher than that defined with the previous 1999 criteria. PN and PAD frequency was 37.3% and 30.1%, respectively. Foot at-risk prevalence was 40% higher in those with severe Total Symptom Score (PR 1.40, 95% CI 1.09-1.80) and also 39% higher in men than in women (PR 1.39, 95% CI 1.17-1.64). Likewise, diabetes duration of more than ten years had a 25% higher prevalence of foot at-risk (PR 1.25, 95% CI 1.05-1.49), and those older than 60 years had a 20% higher presence of this condition (PR 1.20, 95% CI 1.0011.43). CONCLUSIONS Our hospital faces a substantial burden of diabetic foot risk in men, patients with long diabetes duration, and those with painful neuropathy. More initiatives are required at primary or hospital level to detect this critical condition. Likewise, reference centers with multidisciplinary teams to apply prevention and therapeutic interventions are urgently needed.","PeriodicalId":34965,"journal":{"name":"Review of Diabetic Studies","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Review of Diabetic Studies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1900/RDS.2022.18.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

OBJECTIVE To assess the prevalence of patients at risk of developing diabetic foot complications (i.e. foot at-risk) and its clinical components according to the updated International Working Group on Diabetic Foot (IWGDF) criteria and to describe demographic and diabetes-related characteristics. METHODS We conducted a cross-sectional study at María Auxiliadora Hospital between 2017 and 2018. The criteria for foot at-risk in the IWGDF 2019 risk stratification system are classified into four risk categories, R0-R3, ranging from no peripheral arterial disease (PAD) and no peripheral neuropathy (PN) to the presence of PAD or PN in combination with previous foot ulcer, amputation, or end- stage renal disease (R3). According to this system, we obtained prevalence ratios (PR) of foot at-risk categories dependent on sex, age, diabetes duration, and Total Symptom Score. A sample size of 402 subjects was included in the study. RESULTS Subjects included had a mean age of 61 years, and 66% were female. There were no patients with type 1 diabetes, and 59% percent had adiabetes duration of less than ten years. The prevalence of foot at-risk was 54.3% defined by the IWGDF 2019 criteria, which gave prevalence17% higher than that defined with the previous 1999 criteria. PN and PAD frequency was 37.3% and 30.1%, respectively. Foot at-risk prevalence was 40% higher in those with severe Total Symptom Score (PR 1.40, 95% CI 1.09-1.80) and also 39% higher in men than in women (PR 1.39, 95% CI 1.17-1.64). Likewise, diabetes duration of more than ten years had a 25% higher prevalence of foot at-risk (PR 1.25, 95% CI 1.05-1.49), and those older than 60 years had a 20% higher presence of this condition (PR 1.20, 95% CI 1.0011.43). CONCLUSIONS Our hospital faces a substantial burden of diabetic foot risk in men, patients with long diabetes duration, and those with painful neuropathy. More initiatives are required at primary or hospital level to detect this critical condition. Likewise, reference centers with multidisciplinary teams to apply prevention and therapeutic interventions are urgently needed.
秘鲁一家公立医院糖尿病门诊患者足部危险患病率及其相关特征
目的根据最新的国际糖尿病足工作组(IWGDF)标准,评估糖尿病足并发症(即高危足)患者的患病率及其临床组成部分,并描述人口统计学和糖尿病相关特征。方法我们于2017 - 2018年在María Auxiliadora医院进行了一项横断面研究。IWGDF 2019风险分层系统中的足部危险标准分为四个风险类别,R0-R3,范围从无外周动脉疾病(PAD)和无周围神经病变(PN)到PAD或PN合并既往足部溃疡、截肢或终末期肾脏疾病(R3)。根据该系统,我们根据性别、年龄、糖尿病病程和总症状评分获得足部高危类别的患病率(PR)。本研究共纳入402名受试者。结果纳入的受试者平均年龄61岁,其中66%为女性。没有1型糖尿病患者,59%的患者糖尿病持续时间少于10年。IWGDF 2019年标准定义的高危足患病率为54.3%,比1999年之前标准定义的患病率高17%。PN和PAD的发生率分别为37.3%和30.1%。总症状评分严重的患者足部危险患病率高40% (PR = 1.40, 95% CI = 1.09-1.80),男性足部危险患病率也比女性高39% (PR = 1.39, 95% CI = 1.17-1.64)。同样,糖尿病病程超过10年的患者足部风险患病率高出25% (PR为1.25,95% CI 1.05-1.49), 60岁以上的患者足部风险患病率高出20% (PR为1.20,95% CI为1.0011.43)。结论我院男性、糖尿病病程长、疼痛性神经病变患者糖尿病足风险负担较大。需要在基层或医院一级采取更多举措,以发现这一危急情况。同样,迫切需要具有多学科团队的参考中心来应用预防和治疗干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Review of Diabetic Studies
Review of Diabetic Studies Medicine-Internal Medicine
CiteScore
1.80
自引率
0.00%
发文量
28
期刊介绍: The Review of Diabetic Studies (RDS) is the society"s peer-reviewed journal published quarterly. The purpose of The RDS is to support and encourage research in biomedical diabetes-related science including areas such as endocrinology, immunology, epidemiology, genetics, cell-based research, developmental research, bioengineering and disease management.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信